ARTICLE | Company News
EUSA acquires global rights to J&J's Sylvant
July 20, 2018 4:04 PM UTC
Johnson & Johnson (NYSE:JNJ) granted EUSA Pharma Ltd. (Hemel Hempstead, U.K.) worldwide rights to Sylvant siltuximab for $115 million in cash...
BCIQ Target Profiles